The State of Real-World Evidence Policy 2025

Convened with the Duke-Margolis Real-World Evidence Collaborative, this public meeting will provide a venue to review recent RWE Collaborative activities, strategic real-world data and real-world evidence (RWD/E) policy developments, and promising future applications of RWD/E.

Convened with the Duke-Margolis Real-World Evidence Collaborative, this public meeting will provide...

Read More

On the RISE: Controls in Rare Disease Clinical Trials for Small and Diminishing Populations

WASHINGTON, DC

Conducting clinical trials in rare disease populations continues to pose many unique challenges, especially for small and diminishing populations, despite the existence of regulatory guidance on how to perform controls in rare disease trials and an increase in approvals for drugs and biologics to...

Conducting clinical trials in rare disease populations continues to pose many unique challenges,...

Read More